Lv5
1098 积分 2023-11-29 加入
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
2天前
已完结
Darwin’s gemmules and extracellular vesicles: A striking resemblance
2天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
2天前
已完结
Clinical Trial to Evaluate BCMA Car-T (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma
11天前
已关闭
Five‐Year Follow‐Up: Tandem CD19 / CD20 CAR T Therapy Enduring Impact on Refractory/Relapsed Non‐Hodgkin Lymphoma
12天前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
12天前
已完结
Post-CAR-T Cell Therapy (Consolidation and Relapse): Lymphoma
16天前
已完结
Resistance and recurrence of malignancies after CAR-T cell therapy
16天前
已完结
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy
16天前
已完结
皖公网安备34019202002308
